Andrés Escallón

Andrés Escallón has extensive work experience in the healthcare and pharmaceutical industry. Andrés is currently the Vice President of eCOA Solutions Strategy at Suvoda, where they are responsible for developing strategies related to electronic clinical outcome assessments. Prior to this role, they served as the Vice President of eCOA Practice at Suvoda.

Before joining Suvoda, Andrés held leadership positions at SignalPath and ERT. At SignalPath, they served as the Vice President of Digitization, overseeing the implementation of digital solutions in the organization. At ERT, they had multiple roles, including Director of eCOA Clinical Data Management and Program Manager, where they managed various eCOA projects and relationships with key accounts.

Andrés also has experience working at PHT Corporation, where they served as a Program Manager and Senior Project Manager. In these roles, they managed the delivery of software, hardware, and services to pharmaceutical clients and established governance models for consistent project delivery. Earlier in their career, Andrés worked at the Dana-Farber Cancer Institute and Harvard Medical School in financial and administrative roles.

Throughout their career, Andrés has demonstrated expertise in eCOA technologies and has managed projects in various therapeutic areas, including respiratory, CNS, female sexual dysfunction, gastrointestinal, rare disease studies, and oncology. Andrés has a strong track record of building and leading teams, implementing process improvements, and maintaining successful relationships with clients.

Andrés Escallón has attended Boston University and Wellesley High School, although the specific years and degrees obtained are unknown.